AfroCentric Investment Corporation Limited

AfroCentric Investment Corporation Limited

JJSE:ACT
63.00
ZAC
-8.00
(-11.27%)
73.70BMarket Cap
AfroCentric Investment Corporation Limited
JSE:ACT
(Johannesburg Stock Exchange)

Recent

price

63.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2025
TTM
ZAR
5.11
5.42
6.57
5.09
4.48
5.69
6.83
7.6
9.44
11.17
14.05
15.1
14.65
4.48
10.11
8.69
- -
Revenue per Share
0.44
0.67
0.68
0.4
0.33
0.25
0.21
0.46
0.48
0.53
0.53
0.54
0.31
-0.15
-0.03
-1.52
- -
Basic EPS, GAAP
0.1
0.19
0.5
0.15
-0.12
-0.16
-0.08
-0.42
-0.06
0.14
-0.19
0.39
0.21
0.14
0.35
0.55
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
2.73
3.29
3.72
2.29
2.38
1.9
3.26
3.51
3.66
3.87
4.06
4.24
4.23
3.97
- -
2.33
2.41
Book Value per Share
0.44
1.01
1.39
1
0.77
-0.62
0.6
0.36
-0.81
-0.84
-0.8
-1.11
0.49
0.86
- -
1.05
1.19
Tangible Book Value per Share
265
267
269
385
468
553
554
554
561
575
575
576
598
841
841
841
819
Basic Weighted Avg Shares
1,351
1,448
1,770
1,958
2,098
3,148
3,785
4,213
5,297
6,419
8,074
8,693
8,760
3,765
8,503
7,303
- -
Sales/Revenue/Turnover
16.51
26.17
25.25
25.99
28.44
22.68
23.12
24.83
25.04
36.05
42.85
10.11
20.54
8.83
12.7
2.18
- -
Operating Margin (%)
- -
74
77
84
84
117
132
141
250
298
340
382
357
192
396
393
- -
Depreciation Expense
117
180
184
154
154
140
118
257
270
304
302
313
184
-126
-29
-1,274
- -
Net Income, GAAP
26.65
19.08
31.55
30.73
36.01
28.58
39.99
28.52
27.15
25.03
29.41
28.22
30.8
25.43
110.51
- -
- -
Effective Tax Rate (%)
8.68
12.46
10.4
7.85
7.34
4.46
3.11
6.09
5.1
4.73
3.74
3.6
2.09
-3.34
-0.34
-17.45
- -
Profit Margin (%)
100
194
290
413
237
351
588
467
400
285
520
307
304
560
- -
172
826
Working Capital
221
213
205
116
20
21
19
16
633
448
812
659
705
658
- -
633
639
LT Debt
748
913
1,053
1,124
1,167
1,564
2,379
2,620
2,883
3,119
3,256
3,426
3,499
3,279
- -
1,943
2,017
Total Equity
17.86
19.7
18.77
13.27
14.1
13.67
17.07
17.78
29.21
46.32
60.11
14.61
29.24
7.58
- -
- -
- -
Return on Invested Capital (%)
13.12
16.82
14.3
11.55
10.69
7.55
2.15
5.12
5.93
5.36
4.31
4.72
3.12
-2.41
- -
- -
- -
Return on Capital (%)
17.41
22.42
19.53
14.83
14.16
13.04
8.28
13.74
13.37
14.08
13.29
13.13
6.24
-3.76
- -
- -
- -
Return on Common Equity (%)

Capital Structure

ZAR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
142
111
118
LT Borrowings
582
574
577
LT Finance Leases
74
59
62
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
817
818
819
Market Capitalization
1,413
1,087
737

Working Capital

ZAR

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
1,831
1,529
1,942
Cash, Cash Equivalents & STI
483
627
725
Accounts Receivable, Net
712
305
511
Inventories
412
107
88
Total Current Liabilities
1,208
1,357
1,116
Payables & Accruals
- -
- -
- -
ST Debt
142
111
118
Deferred Revenue
- -
- -
- -

Growth Rates

ZAR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
-42.25%
-28.39%
57.89%
Net Income, GAAP
415.98%
808.15%
4,324.19%
Sales/Revenue/Turnover
16.73%
12.62%
-14.11%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

ZAR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
3,765
2025
- -
- -
7,303
2026
- -
- -
- -

Semi-annual Earnings Per Share

ZAR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.15
2025
- -
- -
-1.52
2026
- -
- -
- -

Semi-annual Dividends Per Share

ZAR

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -
Business
AfroCentric Investment Corporation Limited AfroCentric Investment Corporation Limited (ACT.JO) is a South Africa-based Level 1 B-BBEE investment holding company listed on the Johannesburg Stock Exchange that owns and operates diversified healthcare-related enterprises across Southern Africa, providing medical scheme administration, health risk management, pharmaceutical solutions, and corporate health services to public and private sectors. The company, incorporated in 1988 and headquartered at 37 Conrad Road, Florida North, Roodepoort, operates through three primary clusters: Health Administration and Managed Care, encompassing medical scheme administration via Medscheme (South Africa's largest health risk provider serving clients like Bonitas, Fedhealth, GEMS, and Polmed), health risk management through Aid for AIDS (HIV/AIDS programs), Klinikka (musculoskeletal care), and DENIS (dental management); Pharmaceutical Solutions, including Pharmacy Direct (specialist courier pharmacy), Curasana (wholesaler), Activo Health (manufacturer and distributor), Scriptpharm Risk Management (chronic medicine management), and Forrester Pharma; and Corporate Solutions (trading as Sanlam Health), featuring EssentialMed (health insurance), AfroCentric Wellness (wellness programs), AfroCentric WorkCare (onsite healthcare), AfroCentric HealthInsure (gap cover), AfroCentric Employee Health Solutions (occupational health), and AfroCentric Integrated Health Administrators. Subsidiaries and brands such as AfroCentric Technologies (IT solutions), Afrocentric Distribution Services (marketing), and operations in Namibia, Mauritius, and Botswana extend its geographic footprint, managing over 4 million lives with nearly 6,000 employees. In recent developments, Sanlam Life Insurance Limited acquired a controlling 60% stake in AfroCentric in 2023, building on its prior 28.7% holding in subsidiary AfroCentric Healthcare Assets Proprietary Limited and integrating AfroCentric's offerings into Sanlam's ecosystem for enhanced synergies in financial products like insurance and wealth management; the company maintains strategic focus on innovation, including Hospital-at-Home, virtual care, and speech analytics, while positioning for South Africa's National Health Insurance through digital transformation and cost management.